LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 105 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.

Quarter-by-quarter ownership
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q3 2018$8,000
-20.0%
2,8000.0%0.00%
Q2 2018$10,000
-9.1%
2,800
-22.2%
0.00%
Q1 2018$11,000
-52.2%
3,6000.0%0.00%
Q4 2017$23,000
-8.0%
3,6000.0%0.00%
Q3 2017$25,000
+4.2%
3,6000.0%0.00%
Q2 2017$24,000
-27.3%
3,6000.0%0.00%
-100.0%
Q1 2017$33,000
+120.0%
3,6000.0%0.00%
Q4 2016$15,0000.0%3,600
-5.3%
0.00%
Q3 2016$15,000
-6.2%
3,8000.0%0.00%
Q2 2016$16,000
+23.1%
3,800
+35.7%
0.00%
Q1 2016$13,000
-53.6%
2,8000.0%0.00%
-100.0%
Q4 2015$28,000
-78.9%
2,8000.0%0.00%
-66.7%
Q3 2015$133,0000.0%2,8000.0%0.00%0.0%
Q2 2015$133,000
+29.1%
2,8000.0%0.00%0.0%
Q1 2015$103,000
-53.6%
2,800
-50.0%
0.00%0.0%
Q4 2014$222,000
+296.4%
5,600
+100.0%
0.00%
+50.0%
Q3 2014$56,000
+47.4%
2,8000.0%0.00%
+100.0%
Q2 2014$38,000
+26.7%
2,8000.0%0.00%0.0%
Q1 2014$30,000
+172.7%
2,800
+250.0%
0.00%
Q4 2013$11,0008000.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2015
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 317,900$11,647,0004.28%
Opaleye Management Inc. 175,000$6,412,0002.98%
Graticule Asia Macro Advisors LLC 413,200$15,139,0002.02%
BB BIOTECH AG 1,477,114$54,121,0001.61%
Iguana Healthcare Management, LLC 75,000$2,748,0001.16%
Granite Point Capital Management, L.P. 79,250$2,904,0001.06%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 458,202$16,788,0000.89%
Ghost Tree Capital, LLC 130,000$4,764,0000.86%
SECTORAL ASSET MANAGEMENT INC 605,393$22,182,0000.84%
HealthCor Management, L.P. 467,200$17,118,0000.82%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders